High-dose Intravenous Immunoglobulin for Myasthenia Gravis

アクセス数 : 770
ダウンロード数 : 116

今月のアクセス数 : 0
今月のダウンロード数 : 0
File
HiroshimaJMedSci_37_7.pdf 309 KB 種類 : fulltext
Title ( eng )
High-dose Intravenous Immunoglobulin for Myasthenia Gravis
Creator
Sakano Takashi
Hamasaki Takashi
Shimizu Hiroshi
Harada Yoshiaki
Ueda Kazuhiro
Source Title
Hiroshima Journal of Medical Sciences
Volume 37
Issue 1
Start Page 7
End Page 9
Journal Identifire
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
Abstract
A 7-year-old girl with ocular myasthenia gravis (MG) refractory to prednisolone and anticholinesterase compounds was treated with high-dose intravenous immunoglobulin (IVIg). Ocular symptoms disappeared rapidly by the administration of IVIg 300 mg/kg/day for five consecutive days. Booster infusions of IVIg at an interval of 2 weeks appeared to be effective in maintaining a remission at least as an adjunct to prednisolone. The levels of acetylcholine receptor (AchR) antibodies were not correlated with clinical improvement or aggravation. Thus, high-dose IVIg may be useful in refractory cases of MG, allowing a reduction in doses of immunosuppressive drugs.
Keywords
Intravenous immunoglobulin
Myasthenia gravis
NDC
Medical sciences [ 490 ]
Language
eng
Resource Type departmental bulletin paper
Publisher
Hiroshima University Medical Press
Date of Issued 1988-03
Publish Type Version of Record
Access Rights open access
Source Identifier
[ISSN] 0018-2052
[NCID] AA00664312
[PMID] 3410736